fda approval semaglutide mash WEGOVY GETS APPROVAL: The weight-loss drug Wegovy just got to treat a common and serious liver condition known as (Metabolic Dysfunction-Associated Steatohepatitis), adding to a long list of benefits Semaglutide Gets FDA Greenlight for

The starting dose is 2mg administered once weekly by subcutaneous injection

Forty-eight hours out, avoid alcohol (it amplifies post-procedure redness and prolongs swelling), skip aspirin and high-dose fish oil if you arent on them for a medical reason, and do not book a workout in the four hours before your session

Dose modeling research suggested that patients might receive even more benefits with little extra risk at a 7.2 mg dose, a concept that was tested in the STEP UP trials (STEP UP Obesity and STEP UP Diabetes)

This creates a potential for confounding , where the association between medication use and fatty liver may reflect the underlying disease rather than a drug effect

Its main job is to keep you and others safe from accidental needlesticks